Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 29, 2004

View Archived Issues

Japanese approval for Hepsera

New indication for Sandostatin injection approved in Japan

FDA approval for Fosrenol

Guilford researchers present novel NAALADase inhibitors

Novel antibacterial methionyl tRNA synthetase inhibitors claimed by Replidyne

New antirotavirus agents prepared and tested at ViroPharma

Encysive scientists design new urotensin II antagonists

New GSK-3beta inhibitors and their use in Alzheimer's disease and other disorders

New alpha2delta-selective calcium channel ligands discovered at Pfizer

Gruenenthal describes new NOS inhibitors with analgesic activity

New fungal derivative with antitumor and antiproliferative properties

Enrollment progressing ahead of schedule in Ranexa angina study

CuraGen highlights pipeline progression

CuraGen and Bayer advance diabetes compound into preclinical development

Merck KGaA grants Lilly rights to 5-HT2A antagonist for insomnia

Serono and Paratek to develop oral disease-modifying treatment for MS

Approvable letter for Alvesco for persistent asthma

Allergan files IND for neuropathic pain compound

Cloretazine receives orphan drug status

Phase II study of IMOxine in renal cell carcinoma opens enrollment

GlaxoSmithKline acquires rights to Albugon

Lobeline enters clinical trials for methamphetamine addiction

Clearazide set to enter phase II/III studies in 2005

Novo Nordisk terminates development of balaglitazone

CY-401 active against VRSA in preclinical study

International Wex Technologies changes corporate name

Preclinical and clinical data support the efficacy of DA-8159 in erectile dysfunction

Torcetrapib increases plasma HDL cholesterol levels and prevents atherosclerosis in rabbits

Short-term efficacy of a combination of JTT-705 plus pravastatin in type II dyslipidemia

Rimonabant reported to improve insulin response in obese patients with dyslipidemia

Clinical phase I/II data on CAT-192 in diffuse systemic sclerosis

AMG-714 safe, active in rheumatoid arthritis

TNF-alpha antibody evaluated in rheumatoid arthritis patients

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...